Trial · NCT05504863
RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study
NCT05504863, Unknown, Thomas Jefferson University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study. Trials, record NCT05504863. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05504863
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- RAPIDIRON Trial Follow-up Study: RAPIDIRON-KIDS Study
- NCT number
- NCT05504863
- Status
- Unknown
- Enrollment
- 538 participants, actual
- Lead sponsor
- Thomas Jefferson University
- Conditions
- Iron Deficiency Anemia, Neurodevelopmental Abnormality, Autism Spectrum Disorder
- Interventions
- Ferric carboxymaltose, Iron isomaltoside, Ferric Sulfate
- First posted
- 2022-08-17
- Last updated
- 2023-11-29
Source ClinicalTrials.gov
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Offspring hemoglobin | Birth | Offspring hemoglobin concentration in g/dL |
| Primary | Offspring hemoglobin | 4 months of age | Offspring hemoglobin concentration in g/dL |
| Primary | Offspring ferritin | Birth | Offspring serum ferritin concentration in ng/mL |
| Primary | Offspring ferritin | 4 months of age | Offspring serum ferritin concentration in ng/mL |
| Primary | Cognitive Domain of Bayley Scales of Infant Development (BSID) | 24 months of age | Developmental quotient (DQ) on the cognitive domain of the Bayley Scales of Infant Development (BSID), conducted at 24 months of age. The Cognitive Domain of the BSID-IV contains 81 items, each item with a minimum score of 0 and a maximum score of 2. A lower score is a bad outcome and a higher score is a good outcome. |
| Secondary | Offspring hemoglobin | 12 months of age | Offspring hemoglobin concentration in g/dL |
| Secondary | Offspring ferritin | 12 months of age | Offspring serum ferritin concentration in ng/mL |
| Secondary | Preferential Looking Time | 4 and 12 months of age | Performance on Preferential Looking Time assessment - scored as the percentage of time spent looking at the novel object during the test phase |
| Secondary | Motor and language domains of the Bayley Scales of Infant Development (BSID) | 24 months of age | Developmental quotient (DQ) on the motor and language domains of the Bayley Scales of Infant Development (BSID), conducted at 24 months of age. The motor domain of the BSID-IV contains 79 items, and the language domain contains 104 items. Minimum score on each item is 0, maximum score is 2. A lower score is a bad outcome and a higher score is a good outcome. |
| Secondary | Bayley Scales of Infant Development (BSID) | 36 months of age | Developmental quotients (DQs) on all domains of the Bayley Scales of Infant Development (BSID), conducted at 36 months of age. There are 5 domains, each many items. Each item has a minimum score of 0 and a maximum score of 2. A lower score is a bad outcome and a higher score is a good outcome. |
1 to 10 of 24Source ClinicalTrials.gov
See all 24 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 38124098 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05504863
GET https://conductscience.org/api/trials/v1/NCT05504863/registered?page=2